Three separate primary cancers: lung squamous carcinoma, gastric adenocarcinoma, and hepatocellular carcinoma

Patient Info: Anonymized, Male, 60s

Biomarkers: Multiple primaries: lung squamous markers CK5/6 and P40; gastric cancer HER2 negative; liver cancer markers hepatocyte/GPC3/HSP70/CD34.

As of May 2026, all 3 primary cancers were controlled: lung cancer had no recurrence after surgery, gastric cancer remained in sustained remission on sintilimab maintenance, and hepatocellular carcinoma was controlled after ablation; ECOG performance status was 1.

PubMed CentralRead more →

Suspicious right lower-lobe lung nodule reclassified as benign lipoid pneumonia after VATS wedge resection

Patient Info: Anonymized, Female, 40s

Biomarkers: No cancer biomarkers. Pathology showed benign lipoid pneumonia changes, not confirmed cancer.

Final pathology after VATS wedge resection showed benign lipoid pneumonia rather than lung cancer; long-term follow-up was not available.

PubMed CentralRead more →

Stage IB anorectal melanoma: abdominoperineal resection and 6-month no recurrence

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: Anorectal melanoma markers positive for HMB45, S-100, Melan-A

At 6-month follow-up after abdominoperineal resection with sigmoid colostomy, digital rectal examination, sigmoidoscopy, and CT showed no evidence of recurrence.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Mariana's Patient Story

Patient Info: Mariana, Female, Under 40 | Stage IV

Metastatic Site: Ovary; abdominal wall/peritoneum

Ongoing treatment for Stage IV colon cancer with good response during chemotherapy, allowing oxaliplatin to be stopped while continuing treatment every 2 weeks.

The Patient StoryRead more →

No recurrence 7 months after surgery for a rare lung epithelial-myoepithelial cancer

Patient Info: Anonymized, Male, 60s | Stage I

At 7-month follow-up, there was no sign of recurrence after surgery.

PubMed CentralRead more →

Stage I luminal A invasive ductal breast cancer with post-treatment cognitive symptoms

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: ER 100% positive; PR 95% positive; HER2 score 0 / HER2-negative; Ki-67 10%; P63 negative

As of April 2026, the case focused on survivorship after Stage I luminal A breast cancer treatment, with cognitive complaints after chemotherapy and improved MoCA and depression scores after 12 sessions of tDCS; brain metastases had been ruled out.

PubMed CentralRead more →

Stage IV Colorectal Cancer: David's Patient Story

Patient Info: David, Male | Stage IV

Metastatic Site: Liver; lung; tailbone/bone

Had clear scans after multiple treatments for recurrent Stage IV colon cancer, but a later positive Signatera test suggested possible microscopic disease and more treatment was being planned.

The Patient StoryRead more →

Stage IVA EGFR-mutated lung adenocarcinoma: stable disease on first-line osimertinib

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: EGFR exon 19 deletion; baseline EGFR exon 20 T790M mutation; ALK IHC negative; PD-L1 TPS 30%; TTF-1-positive

Metastatic Site: pleura; malignant pleural-pericardial adhesions

As of April 2026, she had stable disease for more than 9 months on first-line osimertinib, with no progressive disease, no recurrent pleural effusion, ECOG improvement from 2 to 0, and no treatment-related adverse events.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Helen's Survivor Story

Patient Info: Helen, Female, 40s | Stage IV

Metastatic Site: Liver; pelvis

No active tumors / no evidence of disease after liver-directed treatment, liver surgery/ablation, colon resection, and hysterectomy, though she personally described herself as living with cancer and still planned cleanup treatment.

The Patient StoryRead more →

Stage II Breast Cancer: Jenna's Patient Story

Patient Info: Jenna, Female, Under 40 | Stage II

Biomarkers: Hormone receptor-positive; HER2-negative; BRCA inherited gene mutations negative

As of April 2026, Jenna had completed pregnancy-associated chemotherapy and double mastectomy for Stage II HR-positive, HER2-negative breast cancer with 1 involved lymph node, did not need radiation, and was on hormone therapy for 10 years.

Early-stage synchronous lung cancers: tumor-free after lobectomy with delayed respiratory and neuropsychiatric complications

Patient Info: Anonymized, Male, 60s

Biomarkers: No molecular biomarkers reported

More than 3 years after thoracoscopic right middle and lower lobectomy, he remained tumor-free, although he had delayed cardiopulmonary, weight-loss, and neuropsychiatric complications after surgery.

PubMed CentralRead more →

Gastric cancer surgery and adjuvant treatment followed by endocrine complications

Patient Info: Anonymized, Female, 40s

After cancer treatment, she was hospitalized with severe nutritional and endocrine complications and improved with hormone replacement and nutritional support.

PubMed CentralRead more →

No recurrence 2 years after surgery for Stage II lung adenocarcinoma

Patient Info: Anonymized, Male, 50s | Stage II

At 2-year follow-up, he remained well with no local recurrence or distant metastasis.

PubMed CentralRead more →

Breast Cancer: Muriel's Patient Story

Patient Info: Muriel, Female

As of 16 April 2026, Muriel was in the antihormonal-therapy phase, living largely symptom-free after breast surgery and chemotherapy, and supporting other people with cancer as a peer counselor.

Stage II Lung Cancer: Michelle's Patient Story

Patient Info: Michelle, Female | Stage II

Receiving ongoing adjuvant treatment after lung cancer first thought to be Stage I was upgraded to Stage IIB because 3 of 18 lymph nodes were positive.

The Patient StoryRead more →

Cancer-free after gastric surgery before a spontaneous twin pregnancy

Patient Info: Anonymized, Female, Under 40

She was described as cancer-free after gastrectomy before conceiving twins in 2024.

PubMed CentralRead more →

Stage IV Breast Cancer: Erica's Patient Story

Patient Info: Erica, Female, 40s | Stage IV

Biomarkers: Hormone-positive; HER2-negative

Metastatic Site: Bone — ribs, sternum, spine, femur/right hip, shoulder…

Living with stable Stage IV hormone-positive, HER2-negative metastatic breast cancer involving multiple bones, currently managed with monthly hormone-suppressant injections and monitoring.

The Patient StoryRead more →

Stage IV Melanoma: Ken's Survivor Story

Patient Info: Ken Herich, Male, 60s | Stage IV

Metastatic Site: Abdomen; shinbone/bone; near lungs

After Stage IV melanoma progressed on prior immunotherapies, TIL therapy produced a complete response; as of April 2026, scans showed no evidence of disease and no sign of melanoma returning nearly 1 year after treatment.

City of HopeRead more →

Invasive Lobular Carcinoma: Liz's Survivor Story

Patient Info: Liz O’Riordan, Female, 40s

Technically cancer-free after 2 local recurrences, with no metastatic disease stated, while continuing lifelong monthly injection treatment to reduce the risk of metastatic disease and living with scanxiety.

The Patient StoryRead more →

Stage III lung cancer treatment complicated by immune-related lung inflammation

Patient Info: Anonymized, Male, 60s | Stage III

Biomarkers: EGFR-negative; ALK-negative; ROS1-negative

Mediastinal lymph nodes later enlarged despite additional systemic treatment, prompting radiation and further therapy.

PubMed CentralRead more →

Stage IV EGFR Lung Cancer: Kelsey's Patient Story

Patient Info: Kelsey, Female, Under 40 | Stage IV

Biomarkers: EGFR mutation; later ALK mutation after progression

Metastatic Site: Bone — pelvis and spine/L5

Living with Stage IV lung cancer on a clinical trial after progression, with current treatment described as working and quality of life improved.

The Patient StoryRead more →

Triple-Negative Breast Cancer: Jes's Survivor Story

Patient Info: Jes, Female

Biomarkers: ER-negative; PR-negative; HER2-negative

No evidence of disease after chemotherapy/immunotherapy and bilateral mastectomy; no positive lymph nodes were found, chemotherapy cleared the cancer, and radiation was not needed, though she continued to experience long-term treatment effects.

The Patient StoryRead more →

Hereditary diffuse gastric cancer managed with repeated endoscopic treatment and gastrectomy

Patient Info: Anonymized, Male, 40s

Biomarkers: CDH1 mutation

Two years after total gastrectomy, he remained free of recurrence.

PubMed CentralRead more →

Stage II EGFR Non-Small Cell Lung Cancer: Daniel's Patient Story

Patient Info: Daniel West, Male, 50s | Stage II

Biomarkers: EGFR positive

As of April 2026, Daniel had shown no evidence of active disease for more than 2 years, while remaining on daily osimertinib through June 2026 and receiving checkups and scans every 3 months for stable monitored lung nodules.

MD AndersonRead more →